(48 days)
Stryker AlphaVent PEEK Suture Anchor (K231093)
No
The 510(k) summary describes a mechanical bone anchor and its performance characteristics, with no mention of AI or ML technology in the intended use, device description, or performance studies.
Yes
The device is intended for soft-tissue to bone fixation in various parts of the body, addressing repairs, reconstructions, and reattachments, which are therapeutic interventions.
No
The device is a PEEK anchor used for soft-tissue to bone fixation in various parts of the body, not for diagnosing conditions.
No
The device description clearly states it is a physical bone anchor made of PEEK with a stainless-steel inserter, intended for surgical implantation. It is a hardware device, not software.
Based on the provided information, the AlphaVent Knotless SP PEEK Anchor is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly states the device is for "soft-tissue to bone fixation" in various anatomical locations. This is a surgical procedure performed in vivo (within the body).
- Device Description: The description details a "bone anchor with a screw-in mechanism" made of PEEK, designed for insertion into bone. This is a physical implantable device.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples) to provide information for diagnosis, monitoring, or screening.
IVD devices are used in vitro (outside the body) to analyze biological samples. The AlphaVent Knotless SP PEEK Anchor is a surgical implant used in vivo.
N/A
Intended Use / Indications for Use
The AlphaVent Knotless SP PEEK Anchor is intended to be used for soft-tissue to bone fixation in the shoulder, foot and ankle, knee, hand and wrist, elbow, and hip in skeletally mature pediatric and adult patients. It is indicated for use in the following procedures:
Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction
Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Hallux Valgus Reconstruction, Mid-foot Reconstruction, Metatarsal Ligament Repair/Tendon Repair
Knee: Anterior Cruciate Ligament Repair, Medial Collateral Ligament Repair, Lateral Collateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis, Quadriceps Tendon Repair, Secondary or Adjunct Fixation for ACL/PCL Reconstruction or Repair, Meniscal Root Repair, MPFL Repair/Reconstruction
Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction
Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Reconstruction, Lateral Epicondylitis Repair
Hip: Capsular Repair, Acetabular Labral Repair, Gluteus Medius Repair, Proximal Hamstring Repair
Product codes
MBI
Device Description
The AlphaVent Knotless SP PEEK Anchors (herein referred to as the subject device(s)) are bone anchors with a screw-in mechanism. The subject device system is comprised of a poly-ether-etherketone (PEEK) eyelet and anchor body, pre-assembled onto a disposable stainless-steel inserter, which enables insertion of the anchor into bone via self-punching or after creation of a pilot hole. The devices are single use, provided sterile, and are packaged in sterile barrier systems (SBS). The AlphaVent Knotless SP PEEK Anchors are sterilized via Ethylene Oxide to a Sterility Assurance Level of 106. The devices are intended to be used in a professional healthcare facility.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
shoulder, foot and ankle, knee, hand and wrist, elbow, and hip
Indicated Patient Age Range
skeletally mature pediatric and adult patients
Intended User / Care Setting
professional healthcare facility
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical benchtop testing was performed to evaluate the performance characteristics of the AlphaVent Knotless SP PEEK Anchors, including ultimate tensile strength (UTS) and insertion testing. The proposed devices demonstrated equivalent or higher UTS as compared to the predicate devices as well as successful insertion, and no new issues of safety and effectiveness were identified.
A biological risk assessment was completed, and the devices met the requirements of ISO10993-1.
Bacterial endotoxin testing has been performed to ensure the device meets pyrogen limit specifications. The limulus amebocyte lysate (LAL) test, kinetic chromogenic method, was performed according to USP Bacterial Endotoxins Test. The LAL testing met the limit acceptance criterion of
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the FDA acronym with the agency's full name on the right. The symbol on the left is a stylized representation of a human figure, while the text on the right reads "FDA U.S. FOOD & DRUG ADMINISTRATION" in blue letters. The FDA is a federal agency responsible for regulating and supervising the safety of food, drugs, and other products.
January 25, 2024
Stryker Endoscopy Madison Mutchler Senior Regulatory Affairs Specialist 5900 Optical Court San Jose, California 95138
Re: K233893
Trade/Device Name: AlphaVent Knotless SP PEEK Anchor Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: MBI Dated: December 8, 2023 Received: December 8, 2023
Dear Madison Mutchler:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Sara S. Thompson -S
For
Jesse Muir, Ph.D. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
Enclosure
3
Indications for Use
Submission Number (if known)
Device Name
AlphaVent Knotless SP PEEK Anchor
Indications for Use (Describe)
The AlphaVent Knotless SP PEEK Anchor is intended to be used for soft-tissue to bone fixation in the shoulder, foot and ankle, knee, hand and wrist, elbow, and hip in skeletally mature pediatric and adult patients. It is indicated for use in the following procedures:
Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromioclavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction
Foot/Ankle: Lateral Stabilization. Medial Stabilization. Achilles Tendon Repair, Hallux Valqus Reconstruction, Mid-foot Reconstruction, Metatarsal Ligament Repair/Tendon Repair
Knee: Anterior Cruciate Ligament Repair, Medial Collateral Ligament Repair, Lateral Collateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis, Quadriceps Tendon Repair, Secondary or Adjunct Fixation for ACL/PCL Reconstruction or Repair, Meniscal Root Repair, MPFL Repair/Reconstruction
Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction
Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Reconstruction, Lateral Epicondylitis Repair
Hip: Capsular Repair, Acetabular Labral Repair, Gluteus Medius Repair, Proximal Hamstring Repair
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
ver-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary
Submitter:
| Applicant | Stryker Endoscopy
5900 Optical Court
San Jose, CA 95138 |
|----------------|--------------------------------------------------------------------------------------------------------------------------|
| Contact Person | Madison Mutchler
Senior Regulatory Affairs Specialist
Phone: (408) 754-2000
Email: madison.mutchler@stryker.com |
| Date Prepared | December 8, 2023 |
Subject Device:
| Name of Device | AlphaVent Knotless SP PEEK Anchor |
|---|---|
| Device Size | 4.75mm, 5.5mm, 6.5mm |
| Common or Usual Name | Suture, Fastener, Fixation, Nondegradable, Soft Tissue |
| Classification Name | Fastener, Fixation, Nondegradable, Soft Tissue, 21 CFR 888.3040 |
| Regulatory Class | Class II |
| Product Code | MBI |
Predicate and Reference Devices:
| Name of Device | Predicate – Arthrex SwiveLock Anchor (K203495) |
|---|---|
| Reference – Stryker AlphaVent PEEK Suture Anchor (K231093) |
Device Description:
The AlphaVent Knotless SP PEEK Anchors (herein referred to as the subject device(s)) are bone anchors with a screw-in mechanism. The subject device system is comprised of a poly-ether-etherketone (PEEK) eyelet and anchor body, pre-assembled onto a disposable stainless-steel inserter, which enables insertion of the anchor into bone via self-punching or after creation of a pilot hole. The devices are single use, provided sterile, and are packaged in sterile barrier systems (SBS). The AlphaVent Knotless SP PEEK Anchors are sterilized via Ethylene Oxide to a Sterility Assurance Level of 106. The devices are intended to be used in a professional healthcare facility.
Intended Use:
The AlphaVent Knotless SP PEEK Anchor is intended to be used for soft-tissue to bone fixation in the shoulder, foot and ankle, knee, hand and wrist, elbow, and hip in skeletally mature pediatric and adult patients. It is indicated for use in the following procedures:
Shoulder: Rotator Cuff Repair, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction
Foot/Ankle: Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Hallux Valgus Reconstruction, Mid-foot Reconstruction, Metatarsal Ligament Repair/Tendon Repair
5
Knee: Anterior Cruciate Ligament Repair, Medial Collateral Ligament Repair, Lateral Collateral Ligament Repair, Patellar Tendon Repair, Posterior Oblique Ligament Repair, Iliotibial Band Tenodesis, Quadriceps Tendon Repair, Secondary or Adjunct Fixation for ACL/PCL Reconstruction or Repair, Meniscal Root Repair, MPFL Repair/Reconstruction
Hand/Wrist: Scapholunate Ligament Reconstruction, Ulnar or Radial Collateral Ligament Reconstruction
Elbow: Biceps Tendon Reattachment, Ulnar or Radial Collateral Reconstruction, Lateral Epicondylitis Repair
Hip: Capsular Repair, Acetabular Labral Repair, Gluteus Medius Repair, Proximal Hamstring Repair
Comparison of Technological Characteristics with the Predicate Device:
The AlphaVent Knotless SP PEEK Anchor is identical to the predicate devices in terms of intended use, indications for use, raw material intended for implantation, general anchor system design features. It is equivalent in terms of other technological characteristics and performance attributes. Any minor differences between the proposed and predicate device do not raise new questions of safety and effectiveness, and these devices are substantially equivalent based on the criteria described in 21 CFR §807.100.
Performance Testing:
Non-clinical benchtop testing was performed to evaluate the performance characteristics of the AlphaVent Knotless SP PEEK Anchors, including ultimate tensile strength (UTS) and insertion testing. The proposed devices demonstrated equivalent or higher UTS as compared to the predicate devices as well as successful insertion, and no new issues of safety and effectiveness were identified.
A biological risk assessment was completed, and the devices met the requirements of ISO10993-1.
Bacterial endotoxin testing has been performed to ensure the device meets pyrogen limit specifications. The limulus amebocyte lysate (LAL) test, kinetic chromogenic method, was performed according to USP Bacterial Endotoxins Test. The LAL testing met the limit acceptance criterion of